|
1.
|
Wei WQ, Qiao YL, Wang GQ, et al: Progress
in prevention and control of esophageal carcinoma in high-risk
population. J Pract Oncol. 6:371–373. 2001.(In Chinese).
|
|
2.
|
Martin de Civetta MT and Civetta JD:
Carcinogenesis. Salud Publica Mex. 53:405–414. 2011.(In
Spanish).
|
|
3.
|
Weiss RA: Multistage carcinogenesis. Br J
Cancer. 12:1981–1982. 2004. View Article : Google Scholar
|
|
4.
|
Xing F, Saidou J and Watabe K: Cancer
associated fibroblasts (CAFs) in tumor microenvironment. Front
Biosci. 15:166–179. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Sugimoto H, Mundel TM, Kieran MW and
Kalluri R: Identification of fibroblast heterogeneity in the tumour
microenvironment. Cancer Biol Ther. 5:1640–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Erez N, Ttuitt M, Olson P, et al:
Cancer-associated fibroblasts are activated in incipient neoplasia
to orchestrate tumour-promoting inflammation in an
NF-kappaB-dependent manner. Cancer Cell. 17:135–147. 2010.
View Article : Google Scholar
|
|
8.
|
Zhang B, Halder SK, Zhang S and Datta PK:
Targeting transforming growth factor-beta signaling in liver
metastasis of colon cancer. Cancer Lett. 277:114–120. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gholamin M, Moaven O, Memar B, et al:
Overexpression and interactions of interleukin-10, transforming
growth factor beta, and vascular endothelial growth factor in
esophageal squamous cell carcinoma. World J Surg. 33:1439–1445.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Langenskiöld M, Holmdahl L, Falk P, et al:
Increased TGF-beta 1 protein expression in patients with advanced
colorectal cancer. J Surg Oncol. 97:409–415. 2008.PubMed/NCBI
|
|
11.
|
Hawinkels LJ, Verspaget HW, van Duijn W,
et al: Tissue level, activation and cellular localisation of
TGF-beta1 and association with survival in gastric cancer patients.
Br J Cancer. 97:398–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Matsumoto K, Date K, Ohmichi H, et al:
Hepatocyte growth factor in lung morphogenesis and tumour invasion:
role as a mediator in epithelium-mesenchyme and tumour-stroma
interactions. Cancer Chemother Pharmacol. 38(Suppl): S42–S47. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Uchida D, Kawamata H, Omotehara F, et al:
Role of HGF/c-met system in invasion and metastasis of oral
squamous cell carcinoma cells in vitro and its clinical
significance. Int J Cancer. 93:489–496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhou Q, Dong Wang L, Du F, et al: Changes
of TGFbeta1 and TGFbetaRII expression in esophageal precancerous
and cancerous lesions: a study of a high-risk population in Henan,
northern China. Dis Esophagus. 15:74–79. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ren Y, Cao B, Law S, et al: Hepatocyte
growth factor promotes cancer cell migration and angiogenic factors
expression: a prognostic marker of human esophageal squamous cell
carcinomas. Clin Cancer Res. 11:6190–6197. 2005. View Article : Google Scholar
|
|
16.
|
Takada N, Yano Y, Matsuda T, et al:
Expression of immunore-active human hepatocyte growth factor in
human esophageal squamous cell carcinomas. Cancer Lett. 97:145–148.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND; World Health Organization. Classification of Tumours of
the Digestive System. IARC Press; Lyon: 2010
|
|
18.
|
El-Shahat M, Lotfy M, Fahmy L, et al:
Prognostic value of microvessel density, matrix metalloproteinase-9
and p53 protein expression in esophageal cancer. J Egypt Natl Canc
Inst. 16:224–230. 2004.PubMed/NCBI
|
|
19.
|
Rønnov-Jessen L, Petersen OW and Bissell
MJ: Cellular changes involved in conversion of normal to malignant
breast: importance of the stromal reaction. Physiol Rev. 76:69–125.
1996.PubMed/NCBI
|
|
20.
|
Gabbiani G: The myofibroblast in wound
healing and fibrocontractive diseases. J Pathol. 200:500–503. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Mueller MM and Fusenig NE: Friends or
foes-bipolar effects of the tumour stroma in cancer. Nat Rev
Cancer. 4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Fuyuhiro Y, Yashiro M, Noda S, et al:
Upregulation of cancer-associated myofibroblasts by TGF-β from
scirrhous gastric carcinoma cells. Br J Cancer. 105:996–1001.
2011.
|
|
23.
|
Abe R, Donnelly SC, Peng T, et al:
Peripheral blood fibrocytes: differentiation pathway and migration
to wound sites. J Immunol. 166:7556–7562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Tuxhorn JA, McAlhany SJ, Yang F, et al:
Inhibition of transforming growth factor-beta activity decreases
angiogenesis in a human prostate cancer-reactive stroma xenograft
model. Cancer Res. 62:6021–6025. 2002.
|
|
25.
|
Brenmoehl J, Miller SN, Hofmann C, et al:
Transforming growth factor-beta 1 induces intestinal myofibroblast
differentiation and modulates their migration. World J
Gastroenterol. 15:1431–1442. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Masszi A, Di Ciano C, Sirokmány G, et al:
Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin
expression during epithelial-mesenchymal transition. Am J Physiol
Renal Physiol. 284:F911–F924. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Von Rahden BH, Stein HJ, Feith M, et al:
Overexpression of TGF-beta1 in esophageal (Barrett’s)
adenocarcinoma is associated with advanced stage of disease and
poor prognosis. Mol Carcinog. 45:786–794. 2006.PubMed/NCBI
|
|
28.
|
Herrera LJ, El-Hefnawy T, Queiroz de
Oliveira PE, et al: The HGF receptor c-Met is overexpressed in
esophageal adenocarcinoma. Neoplasia. 7:75–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Noma K, Smalley KS, Lioni M, et al: The
essential role of fibroblasts in esophageal squamous cell
carcinoma-induced angiogenesis. Gastroenterology. 134:1981–1993.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Saito H, Tsujitani S, Oka S, et al: The
expression of transforming growth factor-beta1 is significantly
correlated with the expression of vascular endothelial growth
factor and poor prognosis of patients with advanced gastric
carcinoma. Cancer. 86:1455–1462. 1999. View Article : Google Scholar
|
|
31.
|
Grugan KD, Miller CG, Yao Y, et al:
Fibroblast-secreted hepatocyte growth factor plays a functional
role in esophageal squamous cell carcinoma invasion. Proc Natl Acad
Sci USA. 107:11026–11031. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Oshima Y, Yajima S, Yamazaki K, et al:
Angiogenesis-related factors are molecular targets for diagnosis
and treatment of patients with esophageal carcinoma. Ann Thorac
Cardiovasc Surg. 16:389–393. 2010.PubMed/NCBI
|
|
33.
|
Kuperwasser C, Chavarria T, Wu M, et al:
Reconstruction of functionally normal and malignant human breast
tissues in mice. Proc Natl Acad Sci USA. 101:4966–4971. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Bhowmick NA, Chytilt A, Plieth D, et al:
TGF-beta signaling in fibroblasts modulates the oncogenic potential
of adjacent epithelia. Science. 303:848–851. 2004. View Article : Google Scholar : PubMed/NCBI
|
